Seminar “Mathematical modeling helps to better understand the mechanisms B-cell lymphomas acquired resistance to BTK inhibitor treatment”

Seminar “Mathematical modeling helps to better understand the mechanisms B-cell lymphomas acquired resistance to BTK inhibitor treatment”

The event passed
13 Jan 2022
Location
Online
Contact person
Mozokhina Anastasiia
About the event

13 January at 16:30 MSK

Chronic activation of B-cell receptor (BCR) signaling via Bruton tyrosine kinase (BTK) is largely considered to be one of the primary mechanisms driving disease progression in B-cell lymphomas, particularly, ABC DLBCL. Although the BTK-targeting agent ibrutinib has shown promising clinical responses, the presence of primary or acquired resistance is common that leads to disease progression. Resistance to ibrutinib therapy can be mediated through genetic mutations, up-regulation of alternative survival pathways, or other unknown factors that are not targeted by ibrutinib therapy. In this work we did mathematical modeling of signaling pathways and transcriptional perturbations in B-cell lymphoma cells under BTK inhibitor treatment which might leads to ibrutinib resistant phenotype.

Online

Speaker

Yuri Kosinsky, senior principal scientist, M&S Decisions LLC.

Related eventsAll events
2025
23 - 25 Sep
“Food Quality Food Safety” (FQFS-2025) 5th International Conference
2025
24 - 25 Sep
The All-Russian Conference with International Participation “Conference on Oil and Gas Technology and Subsoil Use”
2025
24 Nov - 7 Dec
The Digital Pre-University Faculty organises winter schools ‘Dive into Russian in Moscow’ and ‘Dive into Russian in Moscow: advanced level’ for foreign citizens
2025
30 Jun - 16 Sep
Competition for the Prize of the Federal State Autonomous Educational Institution of Higher Education “Peoples’ Friendship University of Russia Named after Patrice Lumumba” for Scientific Achievements and Contribution in the Field of Chemistry